TARGETED TRAILBLAZER Trademark

Pharmaceutical compounding services; pharmaceutical compounding services in the field of oncology; pharmaceutical compounding services in the field of ophthalmology; pharmaceutical compounding services in the field of neurology; pharmaceutical compounding services in the field of anti-infectives; pharmaceutical compounding services in connection with respiratory disease; pharmaceutical compounding services in connection with cardiovascular disease; pharmaceutical compounding services in connection with metabolic disease; pharmaceutical compounding services in connection with the treatment and prevention of viral infections; pharmaceutical compounding services in connection with diagnostics and imaging; pharmaceutical compounding services in connection with renal disease; pharmaceutical compounding services in connection with gastrointestinal disease; pharmaceutical compounding services in connection with muscular skeletal disease

Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services being scientific research in the nature of conducting clinical trials for others, conducting scientific feasibility studies, technical research in the field of pharmaceutical studies in the fields of development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; scientific research services; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; pharmaceutical research and development services; medical research and development services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; pharmaceutical testing and medical and scientific research, namely, conducting clinical trials for others; medical research and development in the field of oncology; medical research and development in the field of ophthalmology; medical research and development in the field of neurology; medical research and development in the field of anti-infective pharmaceuticals; medical research and development in the field of respiratory disease; medical research and development in the field of cardiovascular disease; medical research and development in the field of metabolic disease; medical research and development in the field of antiviral drugs; medical research and development in the field of diagnostics and imaging; medical research and development in the field of renal disease; medical research and development in the field of gastrointestinal disease; medical research and development in the field of muscular skeletal disease; pharmaceutical drug development services; pharmaceutical drug development services in the field of oncology; pharmaceutical drug development services in the field of ophthalmology; pharmaceutical drug development services in the field of neurology; pharmaceutical drug development services in the field of anti-infectives; pharmaceutical drug development services in connection with respiratory disease; pharmaceutical drug development services in connection with cardiovascular disease; pharmaceutical drug development services in connection with metabolic disease; pharmaceutical drug development services in connection with the treatment and prevention of viral infections; pharmaceutical drug development services in connection with diagnostics and imaging; pharmaceutical drug development services in connection with renal disease; pharmaceutical drug development services in connection with gastrointestinal disease; pharmaceutical drug development services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid

Pharmaceuticals for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for suppressing tumors; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and prevention of respiratory disease; pharmaceutical products and preparations for the treatment and prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and prevention of metabolic disease; pharmaceutical products and preparations for the treatment and prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging for the prevention and treatment of cancer; pharmaceutical products and preparations for the treatment and prevention of renal disease; pharmaceutical products and preparations for the treatment and prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and prevention of muscular skeletal disease